Retatrutide Pen

Retatrutide Pen (LY-3437943) – Research Solution for In-Vitro Use

The Retatrutide Pen is an advanced research solution in which
Retatrutide (LY-3437943) is supplied in a
ready-to-use pen formulation. This format is designed for
controlled, reproducible, and efficient in-vitro laboratory research.
Retatrutide is a triple receptor agonist (GLP-1, GIP, and glucagon receptors)
and is widely studied in endocrine, metabolic, and biochemical research models.

Why choose the Retatrutide Pen from Peptidelabs.eu?

• Ready to use: No reconstitution or dilution required
• Purity: ≥ 99% (HPLC tested)
• Consistency: Fixed concentration for reproducible results
• Variants: Available in multiple dosage options
• Application: Intended exclusively for in-vitro research use

Available variants

• Retatrutide Pen – 10 mg
• Retatrutide Pen – 20 mg
• Retatrutide Pen – 30 mg
• Retatrutide Pen – 40 mg
• Retatrutide Pen – 60 mg

All variants meet the same quality standards and are supplied
sterile and discreetly for use in controlled research environments.

Key specifications

Research relevance

Retatrutide is studied in research settings due to its interaction with
multiple receptor systems involved in
metabolic regulation, endocrine signaling pathways, and biochemical processes.
The pen formulation provides researchers with a practical and consistent method
for applying Retatrutide in in-vitro models,
minimizing variability associated with manual preparation.

• Investigated in preclinical models focused on metabolic signaling pathways.
• Relevant for studies on receptor activation and downstream signal transduction.
• Suitable for controlled laboratory setups without reconstitution steps.
• Pen formulation supports reproducibility across experiments.

Frequently asked questions

Legal notice:
This product is intended exclusively for in-vitro research purposes.
Not intended for human or animal consumption.
Not approved as a medicinal product, medical device, or therapeutic application.